MedTrace Logo

Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain

NCT00797017 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1576

Last updated 2014-04-28

No results posted yet for this study

Summary

The purpose of this observational study is to investigate the impact of fentanyl matrix on improvement of pain and functioning in spinal disorder-related chronic pain.

Conditions

  • Low Back Pain

Interventions

DRUG

fentanyl

Infection, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

(CRPS) Complex Regional Pain Syndrome, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

Bone Fracture, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

(FBSS) Failed Back Surgery Syndrome, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

Other Deformity, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

(LDK) Lumbar Degenerative Kyphosis, starting with 12mcg/h (flexible dose)

DRUG

fentanyl

Degenerative Spine Disorder, starting with 12mcg/h (flexible dose)

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    lead INDUSTRY

Principal Investigators

  • Janssen Korea, Ltd. Clinical Trial · Janssen Korea, Ltd.

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00797017 on ClinicalTrials.gov